MedPharm Ltd.

Guildford, United Kingdommedpharm.com1expert edge

Specialized CDMO founded 1999 focused on topical, transdermal, and transepithelial drug product development and manufacturing. Operates GMP facilities in UK and USA with expertise in dermal, ophthalmic, nasal, and mucosal delivery routes.

Why interesting to a deal team

Prior board chairman Nov 2018-Jan 2024 (Paul H. Johnson) demonstrates specialty CDMO value creation expertise; recent Tergus Pharma merger and Ampersand backing provide exit case study for mid-market topical CDMO platform consolidation.

Experts connected to this company

Paul H. JohnsonBoard chairman, November 2018 to January 2024

Paul H. Johnson

Executive Chairman

Tjoapack

AdvisorSan Antonio

Executive Chairman of Tjoapack and 30-year CDMO operator who sold DPT/Renaissance to Mylan for $950M — brings both operating and PE-diligence lenses to topicals/injectables manufacturing.

Sources

Name + firmPrimary
medpharm.com
Page titlePress
prnewswire.com/news-releases/medpharm-ltd-and-tergus-pharma-merger-forms-topical-and-transdermal-cdmo-leader-302190719.html

Strongest evidencePage title2 public sourcesHow the grades work